GLP-1 Finished Products
-
Tirzepatide Powder for Injection for Weight Loss 30mg Per Vial Purity 99%
Tirzepatide is a novel, dual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It represents a significant advancement in the treatment of type 2 diabetes and has shown promising results in weight management. Tirzepatide injection powder is the pharmaceutical form used to prepare the solution for subcutaneous administration.
Mechanism of Action
Tirzepatide works by activating both GIP and GLP-1 receptors, which are involved in regulating blood sugar levels and appetite. The dual agonism provides several beneficial effects:
- Enhanced Insulin Secretion: It stimulates insulin release in a glucose-dependent manner, helping to lower blood sugar levels without causing hypoglycemia.
- Suppressed Glucagon Release: It reduces the secretion of glucagon, a hormone that raises blood sugar levels.
- Appetite Regulation: It promotes satiety and reduces food intake, contributing to weight loss.
- Slowed Gastric Emptying: It delays the emptying of the stomach, which helps in controlling postprandial blood sugar spikes.
Approved Use
As of the latest updates, Tirzepatide has been approved by regulatory authorities such as the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes. It is also under investigation for its potential use in obesity management.
Benefits
- Effective Glycemic Control: Significant reduction in HbA1c levels.
- Weight Loss: Substantial weight reduction, which is beneficial for patients with type 2 diabetes and obesity.
- Cardiovascular Benefits: Potential improvements in cardiovascular risk factors, although ongoing studies are further evaluating this aspect.
- Convenience: Once-weekly dosing improves patient adherence compared to daily medications.
Potential Side Effects
While Tirzepatide is generally well-tolerated, some users may experience side effects, including:
- Gastrointestinal Issues: Nausea, vomiting, diarrhea, and constipation are common, especially during the initial stages of treatment.
- Risk of Hypoglycemia: Particularly when used in combination with other glucose-lowering medications.
- Pancreatitis: Rare but serious, requiring immediate medical attention if symptoms like severe abdominal pain occur.
Preparation and Administration
Tirzepatide injection powder needs to be reconstituted with a suitable solvent (usually provided in the kit) to form a solution for injection. The reconstituted solution should be clear and free of particles. It is administered subcutaneously in the abdomen, thigh, or upper arm.